Drugs for treating respiratory disease - seminar Flashcards
Main indication for diuretics in small animals?
acute treatment of congestive heart failure,
for cardiogenic pulmonary edema
furosemide
Describe Bronchodilators. (4)
・ are beta 2 adrenoreceptor agonists
・ Methylxanthine derivatives
・ Anticholinergic drugs
Main indication is feline asthma.
Relaxation of airway smooth muscle
Name an injectable bronchodilator used in vet med.
Terbutaline - injectable
indication: acute bronchospasm in suspected feline asthma,
adverse effects: tachycardia, hypotension
Name an inhalatory bronchodilator used in vet med.
Salbutamol - inhaled with a mask
What is Theophylline?
・ Methylxanthine derivative, phosphodiesterase inhibitor, alters intracellular calcium levels.
- found in tea, coffee, chocolate etc.
・ Bronchodilator, enhances mucociliary clearance, stimulates the respiratory centre, increases the sensitivity to the PaCO2, increases diaphragmatic contractility, reduces respiratory effort, mild inotropic and diuretic effect
・ given PO tabl/oral suspension - less valuable in ICU setting
・ Mainly used as adjunct therapy for chronic cough caused by tracheitis and bronchitis
associated with tracheal collapse.
・ Adverse effects: GI signs, tachycardia, hyperexcitability
・ Do not use with beta sympathomimetics - increased adverse effects
・ Acts synergistically with steroids - smaller dose of steroid required
Describe anticholinergic drugs as bronchodilators.
Not used too frequently for bronchodilation in animals (used more in humans for this indication).
e.g. Atropine, glycopyrrolate
・ Compete with acetylcholine at muscarinic receptor sites.
・ Respiratory actions: antagonize vagally mediated bronchoconstriction and decrease
secretions.
・ Not been studied in the treatment of bronchial disease in animals.
・ Indication: acute respiratory distress due to bronchial disease that is refractory to other drugs.
Glucocorticosteroids as bronchodilators.
Dexamethasone, prednisolone
・ More powerful and global anti-inflammatory effect than NSAID.
・ Inhibit metabolism of inflammatory mediators, decrease migration of inflammatory cells into the airway.
・ Acts on beta 2 adrenoreceptors - bronchodilation.
Indications:
・ Acute management of upper airway obstruction/BOAS (tissue edema) and feline asthma (when inj. terbutaline not avail, dexamethasone is used).
・ Long term control of chronic respiratory diseases (feline bronchial disease, canine
chronic bronchitis and eosinophilic lung disease).
Inhaled therapy (fluticasone propionate): metered dose inhaler, spacer with face mask, has delay in the efficacy, so with moderate to severe disease start with oral steroids.
Dogs do not have asthma, they have
eosinophilic lung disease.
Side effects of steroids are more severe in ? Than in?
Side effects: clinical signs of hyperadrenocorticism (PU/PD, PP)
Cats are relatively resistant to side effects, larger dogs seem to suffer more severe or
noticeable side effects with steroids than do smaller dogs.
Glucocorticoids can cause insulin resistance in cats and thus diabetes.
Describe Non-steroidal anti-inflammatory drugs used in treatment of respiratory disease.
・ Do not have clinically significant anti-inflammatory effects in the respiratory tract.
・ With the exception of use as analgesics, are not indicated for treatment of most types of respiratory distress.
・ Should be avoided until cardiovascular stability has been confirmed and the patient evaluated for renal disease.
・ Also antipyretic.
Describe antibiotics used in treatment of respiratory disease.
・ Infectious respiratory disease
・ Bacteriology and antibiogram
・ With bronchiectasis, ciliary dyskinesia -
intermittent/pulse/chronic therapy.
What is Primary ciliary dyskinesia (PCD) disease?
Primary ciliary dyskinesia (PCD) is usually an autosomal recessive genetic condition in which the microscopic organelles (cilia) in the respiratory system have defective function.
Ciliary dysfunction prevents the clearance of mucous from the lungs, paranasal sinuses and middle ears.
Define bronchiectasis.
Bronchiectasis is a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection.
The most common symptoms of bronchiectasis include: a persistent cough that usually brings up phlegm (sputum) shortness of breath.
Indications for use of mucolytics:
excessive production of airway secretions associated with chronic inflammatory disease (chronic bronchitis, bronchiectasis, ciliary dyskinesia, viscid secretions associated with pneumonia) etc.
Describe N-acetylcysteine as a mucolytic.
・ Decreases the viscosity of both purulent and non-purulent airway secretions to facilitate clearance from the respiratory tract.
・ Nebulization is associated with bronchospasm so only use IV/PO.
・ Indication: thick airway secretions that are not readily cleared and risk airway obstruction.